| 1 | 1 | | 1 of 1 |
|---|
| 2 | 2 | | HOUSE DOCKET, NO. 2137 FILED ON: 1/20/2023 |
|---|
| 3 | 3 | | HOUSE . . . . . . . . . . . . . . . No. 3574 |
|---|
| 4 | 4 | | The Commonwealth of Massachusetts |
|---|
| 5 | 5 | | _________________ |
|---|
| 6 | 6 | | PRESENTED BY: |
|---|
| 7 | 7 | | Nicholas A. Boldyga |
|---|
| 8 | 8 | | _________________ |
|---|
| 9 | 9 | | To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General |
|---|
| 10 | 10 | | Court assembled: |
|---|
| 11 | 11 | | The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: |
|---|
| 12 | 12 | | An Act concerning the use of a prescription medicine that contains 3,4- |
|---|
| 13 | 13 | | methylenedioxymethamphetamine (MDMA). |
|---|
| 14 | 14 | | _______________ |
|---|
| 15 | 15 | | PETITION OF: |
|---|
| 16 | 16 | | NAME:DISTRICT/ADDRESS :DATE ADDED:Nicholas A. Boldyga3rd Hampden1/19/2023 1 of 2 |
|---|
| 17 | 17 | | HOUSE DOCKET, NO. 2137 FILED ON: 1/20/2023 |
|---|
| 18 | 18 | | HOUSE . . . . . . . . . . . . . . . No. 3574 |
|---|
| 19 | 19 | | By Representative Boldyga of Southwick, a petition (accompanied by bill, House, No. 3574) of |
|---|
| 20 | 20 | | Nicholas A. Boldyga relative to the use of a certain prescription medication used in |
|---|
| 21 | 21 | | psychotherapy and the treatment of post-traumatic stress disorder. Elder Affairs. |
|---|
| 22 | 22 | | The Commonwealth of Massachusetts |
|---|
| 23 | 23 | | _______________ |
|---|
| 24 | 24 | | In the One Hundred and Ninety-Third General Court |
|---|
| 25 | 25 | | (2023-2024) |
|---|
| 26 | 26 | | _______________ |
|---|
| 27 | 27 | | An Act concerning the use of a prescription medicine that contains 3,4- |
|---|
| 28 | 28 | | methylenedioxymethamphetamine (MDMA). |
|---|
| 29 | 29 | | Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority |
|---|
| 30 | 30 | | of the same, as follows: |
|---|
| 31 | 31 | | 1 SECTION 1. Section 7 of chapter 94C of the General Laws, as appearing in the 2020 |
|---|
| 32 | 32 | | 2Official Edition, is hereby amended by adding the following subsection:- |
|---|
| 33 | 33 | | 3 (j) Any person or entity registered to prescribe, manufacture, distribute, dispense or |
|---|
| 34 | 34 | | 4provide services related to 3,4-methylenedioxymethamphetamine (MDMA) shall not charge |
|---|
| 35 | 35 | | 5more than $5,000 per MDMA treatment service unit. For the purposes of this subsection, |
|---|
| 36 | 36 | | 6“MDMA treatment service unit” shall mean any prescribed and controlled administration of |
|---|
| 37 | 37 | | 7MDMA in any 7-day consecutive period including therapy and related counseling. |
|---|
| 38 | 38 | | 8 SECTION 2. Paragraph (a) of Class B of section 31 of chapter 94C of the General Laws, |
|---|
| 39 | 39 | | 9as so appearing, is hereby amended by striking out clause (8). |
|---|
| 40 | 40 | | 10 SECTION 3. Section 2 of this act shall take effect upon the approval of 3,4– |
|---|
| 41 | 41 | | 11methylenedioxymethamphetamine (MDMA) as a prescription drug by the United States Food 2 of 2 |
|---|
| 42 | 42 | | 12and Drug Administration and the secretary of the commonwealth shall publish notice of the |
|---|
| 43 | 43 | | 13effective date of this act in the Massachusetts Register. |
|---|